The macrocirculation and microcirculation of hypertension

  • François Feihl
  • Lucas Liaudet
  • Bernard WaeberEmail author


Changes in vascular structure that accompany hypertension may contribute to hypertensive end-organ damage. Both the macrovascular and microvascular levels should be considered, as interactions between them are believed to be critically important. Regarding the macrocirculation, the article first reviews basic concepts of vascular biomechanics, such as arterial compliance, arterial distensibility, and stress-strain relationships of arterial wall material, and then reviews how hypertension affects the properties of conduit arteries, particularly examining evidence that it accelerates the progressive stiffening that normally occurs with advancing age. High arterial stiffness may increase central systolic and pulse pressure by two different mechanisms: 1) Abnormally high pulse wave velocity may cause pressure waves reflected in the periphery to reach the central aorta in systole, thus augmenting systolic pressure; 2) In the elderly, the interaction of the forward pressure wave with high arterial stiffness is mostly responsible for abnormally high pulse pressure. At the microvascular level, hypertensive disease is characterized by inward eutrophic or hypertrophic arteriolar remodeling and capillary rarefaction. These abnormalities may depend in part on the abnormal transmission of highly pulsatile blood pressure into microvascular networks, especially in highly perfused organs with low vascular resistance, such as the kidney, heart, and brain, where it contributes to hypertensive end-organ damage.


Pulse Pressure Arterial Stiffness Pulse Wave Velocity Systolic Hypertension Conduit Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Feihl F, Liaudet L, Waeber B, et al.: Hypertension, a disease of the microcirculation? Hypertension 2006, 48:1012–1017.PubMedCrossRefGoogle Scholar
  2. 2.
    Mulvany MJ: Vascular remodelling of resistance vessels: Can we define this? Cardiovasc Res 1999, 41:9–13.PubMedCrossRefGoogle Scholar
  3. 3.
    Feihl F, Liaudet L, Levy BI, et al.: Hypertension and microvascular remodelling. Cardiovasc Res 2008, 78:274–285.PubMedCrossRefGoogle Scholar
  4. 4.
    Zanchi A, Wiesel P, Aubert JF, et al.: Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats. Hypertension 1997, 29:1199–1203.PubMedGoogle Scholar
  5. 5.
    Marque V, Grima M, Kieffer P, et al.: Withdrawal reveals lack of effect of prolonged antihypertensive treatment on intrinsic aortic wall stiffness in senescent spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2002, 29:898–904.PubMedCrossRefGoogle Scholar
  6. 6.
    Lacolley P, Labat C, Pujol A, et al.: Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 2002, 106:2848–2853.PubMedCrossRefGoogle Scholar
  7. 7.
    Louis H, Kakou A, Regnault V, et al.: Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol 2007, 293:H2597–H2604.Google Scholar
  8. 8.
    Laurent S, Girerd X, Mourad JJ, et al.: Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb 1994, 14:1223–1231.PubMedGoogle Scholar
  9. 9.
    Mourad JJ, Girerd X, Boutouyrie P, et al.: Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 1997, 30:1425–1430.PubMedGoogle Scholar
  10. 10.
    Girerd X, Giannattasio C, Moulin C, et al.: Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 1998, 31:1064–1073.PubMedCrossRefGoogle Scholar
  11. 11.
    Bussy C, Boutouyrie P, Lacolley P, et al.: Intrinsic stiffness of the carotid arterial wall material in essential hypertensives. Hypertension 2000, 35:1049–1054.PubMedGoogle Scholar
  12. 12.
    Letavernier E, Perez J, Bellocq A, et al.: Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 2008, 102:720–728.PubMedCrossRefGoogle Scholar
  13. 13.
    Blacher J, Staessen JA, Girerd X, et al.: Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000, 160:1085–1089.PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson RD, Sizemore BC, Barrow GM, et al.: Pulse pressure and adverse outcomes in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE). Am J Hypertension 2008, 21:1224–1230.CrossRefGoogle Scholar
  15. 15.
    Hayoz D, Rutschmann B, Perret F, et al.: Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992, 20:1–6.PubMedGoogle Scholar
  16. 16.
    Laurent S, Caviezel B, Beck L, et al.: Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension 1994, 23:878–883.PubMedGoogle Scholar
  17. 17.
    Laurent S: Arterial wall hypertrophy and stiffness in essential hypertensive patients. Hypertension 1995, 26:355–362.PubMedGoogle Scholar
  18. 18.
    Dart AM, Gatzka CD, Cameron JD, et al.: Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol 2004, 24:962–968.PubMedCrossRefGoogle Scholar
  19. 19.
    Nichols WW, O’Rourke MF: McDonald’s Blood Flow in Arteries, edn 5. London: A Hodder Arnold Publication; 2005.Google Scholar
  20. 20.
    Safar ME, Blacher J, Mourad JJ, et al.: Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention. Stroke 2000, 31:782–790.PubMedGoogle Scholar
  21. 21.
    Boumaza S, Arribas SM, Osborne-Pellegrin M, et al.: Fenestrations of the carotid internal elastic lamina and structural adaptation in stroke-prone spontaneously hypertensive rats. Hypertension 2001, 37:1101–1107.PubMedGoogle Scholar
  22. 22.
    Safar ME: Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens 2005, 23:673–681.PubMedGoogle Scholar
  23. 23.
    Safar ME, Lacolley P: Disturbance of macro- and microcirculation: relations with pulse pressure and cardiac organ damage. Am J Physiol 2007, 293:H1–H7.CrossRefGoogle Scholar
  24. 24.
    Franklin SS, Gustin Wt, Wong ND, et al.: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96:308–315.PubMedGoogle Scholar
  25. 25.
    Mitchell GF, Parise H, Benjamin EJ, et al.: Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004, 43:1239–1245.PubMedCrossRefGoogle Scholar
  26. 26.
    Mitchell GF: Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 2008, 105:1652–1660.PubMedCrossRefGoogle Scholar
  27. 27.
    Zanchi A, Brunner HR, Hayoz D: Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats. J Hypertens 1997, 15:1415–1422.PubMedCrossRefGoogle Scholar
  28. 28.
    Wolinsky H: Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Morphological and chemical studies. Circ Res 1972, 30:301–309.PubMedGoogle Scholar
  29. 29.
    Benetos A, Adamopoulos C, Bureau JM, et al.: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002, 105:1202–1207.PubMedCrossRefGoogle Scholar
  30. 30.
    Laurent S, Cockcroft J, Van Bortel L, et al.: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588–2605.PubMedCrossRefGoogle Scholar
  31. 31.
    Laurent S, Boutouyrie P, Asmar R, et al.: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37:1236–1241.PubMedGoogle Scholar
  32. 32.
    Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39:10–15.PubMedCrossRefGoogle Scholar
  33. 33.
    Laurent S, Katsahian S, Fassot C, et al.: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34:1203–1206.PubMedCrossRefGoogle Scholar
  34. 34.
    O’Rourke MF, Pauca A, Jiang XJ: Pulse wave analysis. Br J Clin Pharmacol 2001, 51:507–522.PubMedCrossRefGoogle Scholar
  35. 35.
    Gallagher D, Adji A, O’Rourke MF: Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertension 2004, 17:1059–1067.CrossRefGoogle Scholar
  36. 36.
    London GM, Blacher J, Pannier B, et al.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38:434–438.PubMedGoogle Scholar
  37. 37.
    Baumbach GL, Heistad EL: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989, 13:968–972.PubMedGoogle Scholar
  38. 38.
    Bakker EN, van der Meulen ET, van den Berg BM, et al.: Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 2002, 39:12–20.PubMedCrossRefGoogle Scholar
  39. 39.
    Martinez-Lemus LA, Hill MA, Bolz SS, et al.: Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: implications for functional remodeling. FASEB J 2004, 18:708–710.PubMedGoogle Scholar
  40. 40.
    Schofield I, Malik R, Izzard A, et al.: Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002, 106:3037–3043.PubMedCrossRefGoogle Scholar
  41. 41.
    Endemann DH, Pu Q, De Ciuceis C, et al.: Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004, 43:399–404.PubMedCrossRefGoogle Scholar
  42. 42.
    Rizzoni D, Palombo C, Porteri E, et al.: Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003, 21:625–631.PubMedCrossRefGoogle Scholar
  43. 43.
    Rizzoni D, Porteri E, Boari GE, et al.: Prognostic significance of small-artery structure in hypertension. Circulation 2003, 108:2230–2235.PubMedCrossRefGoogle Scholar
  44. 44.
    De Ciuceis C, Porteri E, Rizzoni D, et al.: Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertension 2007, 20:846–852.CrossRefGoogle Scholar
  45. 45.
    Mathiassen ON, Buus NH, Sihm I, et al.: Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007, 25:1021–1026.PubMedCrossRefGoogle Scholar
  46. 46.
    Serne EH, Gans ROB, ter Maaten JC, et al.: Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001, 38:238–242.PubMedGoogle Scholar
  47. 47.
    Antonios TFT, Singer DRJ, Markandu ND, et al.: Structural skin capillary rarefaction in essential hypertension. Hypertension 1999, 33:998–1001.PubMedGoogle Scholar
  48. 48.
    Debbabi H, Uzan L, Mourad JJ, et al.: Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 2006, 19:477–483.PubMedCrossRefGoogle Scholar
  49. 49.
    Antonios TFT, Singer DRJ, Markandu ND, et al.: Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999, 34:655–658.PubMedGoogle Scholar
  50. 50.
    Antonios TFT, Rattray FM, Singer DRJ, et al.: Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 2003, 89:175–178.PubMedCrossRefGoogle Scholar
  51. 51.
    Kobayashi N, DeLano FA, Schmid-Schönbein GW: Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 2005, 25:2114–2121.PubMedCrossRefGoogle Scholar
  52. 52.
    Emanueli C, Salis MB, Stacca T, et al.: Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer. Hypertension 2001, 38:136–141.PubMedGoogle Scholar
  53. 53.
    Takeshita S, Tomiyama H, Yokoyama N, et al.: Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 2001, 52:314–320.PubMedCrossRefGoogle Scholar
  54. 54.
    You D, Cochain C, Loinard C, et al.: Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension 2008, 51:1537–1544.PubMedCrossRefGoogle Scholar
  55. 55.
    Safar ME: Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 2001, 10:257–261.PubMedCrossRefGoogle Scholar
  56. 56.
    O’Rourke MF, Safar ME: Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005, 46:200–204.PubMedCrossRefGoogle Scholar
  57. 57.
    Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.PubMedCrossRefGoogle Scholar
  58. 58.
    Lehoux S: Redox signalling in vascular responses to shear and stretch. Cardiovasc Res 2006, 71:269–279.PubMedCrossRefGoogle Scholar
  59. 59.
    Dahlof B, Sever PS, Poulter NR, et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial—Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005, 366:895–906.PubMedCrossRefGoogle Scholar
  60. 60.
    Williams B, Lacy PS, Thom SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213–1225.PubMedCrossRefGoogle Scholar
  61. 61.
    Firbank MJ, Wiseman RM, Burton EJ, et al.: Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol 2007, 254:713–721.PubMedCrossRefGoogle Scholar
  62. 62.
    Waldstein SR, Rice SC, Thayer JF, et al.: Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008, 51:99–104.PubMedCrossRefGoogle Scholar
  63. 63.
    Verhave JC, Fesler P, du Cailar G, et al.: Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 2005, 45:586–591.PubMedCrossRefGoogle Scholar
  64. 64.
    Pedrinelli R, Dell’Omo G, Penno G, et al.: Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 2000, 35:48–54.PubMedGoogle Scholar
  65. 65.
    Arroyo-Espliguero R, Mollichelli N, Avanzas P, et al.: Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J 2003, 24:2006–2011.PubMedCrossRefGoogle Scholar
  66. 66.
    Gorgulu S, Uslu N, Eren M, et al.: Aortic stiffness in patients with cardiac syndrome X. Acta Cardiol 2003, 58:507–511.PubMedCrossRefGoogle Scholar
  67. 67.
    Kingwell BA, Cameron JD, Gillies KJ, et al.: Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol 1995, 268:H411–H418.PubMedGoogle Scholar
  68. 68.
    Levy BI, Schiffrin EL, Mourad JJ, et al.: Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 2008, 118:968–976.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Division de Physiopathologie Clinique, MP-14/204Centre Hospitalier Universitaire Vaudois (CHUV)LausanneSwitzerland

Personalised recommendations